Skip to main content
. 2013 May 28;19(20):3083–3089. doi: 10.3748/wjg.v19.i20.3083

Table 2.

Patients' model for end-stage liver disease and Child-Pugh scores

HIFU (n = 10) TACE (n = 29)
MELD score (P = 0.687)
14 0 2
13 1 4
12 1 4
11 4 7
10 1 3
9 1 3
8 0 1
7 1 4
6 1 1
Child-Pugh score (P = 0.096)
5 0 10
6 3 7
7 5 4
8 1 5
9 0 2
10 1 1

MELD: Model for end-stage liver disease; HIFU: High-intensity focused ultrasound; TACE: Transarterial chemoembolization.